Results 91 to 100 of about 17,265 (196)

A COMPARISON OF THE THERAPEUTIC EFFICACY OF TRANSARTERIAL CHEMOEMBOLIZATION AND COMBINATION THERAPY WITH TRANSARTERIAL CHEMOEMBOLIZATION PLUS SORAFENIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA

A COMPARISON OF THE THERAPEUTIC EFFICACY OF TRANSARTERIAL CHEMOEMBOLIZATION AND COMBINATION THERAPY WITH TRANSARTERIAL CHEMOEMBOLIZATION PLUS SORAFENIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
[Background and Aims] The combination therapy of transarterial chemoembolization (TACE) plus sorafenib has been applied for unresectable hepatocellular carcinoma (HCC). However, its efficacy remains controversial, possibly due to the timing of the initiation of sorafenib treatment.
openaire   +3 more sources

Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization

European Journal of Radiology Open
Purpose: To develop and validate a radiomics machine learning (Rad-ML) model based on preoperative MRI to predict extrahepatic metastasis (EHM) in hepatocellular carcinoma (HCC) patients receiving transarterial chemoembolization (TACE) treatment. Methods:
Gang Peng, Xiaojing Cao, Xiaoyu Huang, Xiang Zhou   +3 more
doaj   +1 more source

Therapeutic Effect Analysis of Radiofrequency Ablation on Transarterial Chemoembolization Postoperative Residual [PDF]

West Indian Medical Journal, 2016
C Shi, B Qiao, Q Yang, B Zheng, X Yu, S Wang   +5 more
openaire   +1 more source

Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma

Journal of Pain Research, 2020
Tian-Cheng Wang, Zi-Shu Zhang, Yu-Dong Xiao Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of ChinaCorrespondence: Yu-Dong Xiao Email xiaoyudong222@csu.edu.cnPurpose: To identify
Wang TC, Zhang ZS, Xiao YD
doaj  

Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experience

Cancer Management and Research, 2019
Yu-dong Xiao, Cong Ma, Zi-shu Zhang,* Jun Liu* Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha 410011, China *These authors contributed equally to this work Objective: To evaluate the feasibility and ...
Xiao YD, Ma C, Zhang ZS, Liu J
doaj  

Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: new questions at the dawn of a new era

Journal for ImmunoTherapy of Cancer
Anti-programed cell death protein-1 (PD-1) and anti-programmed cell death 1 ligand 1 (PD-L1) antibodies combined with anti-vascular endothelial growth factor (VEGF) or anti-cytotoxic T lymphocyte antigen 4 (CTLA-4) antibodies are now standard therapeutic
Aruj Dhyani, James J Harding
doaj   +1 more source

A comprehensive review on the current applications and future perspectives of radioembolization in endovascular neurosurgery. [PDF]

J Neurointerv Surg
Liu XYE, Rutka J, Cheng HM, Spears J, Das S, Mendes Pereira V.   +5 more
europepmc   +1 more source

Correction: Editorial: Hepatocellular carcinoma: from bench to bedside. [PDF]

Front Genet
İşcan E, Koenig AB, Wu X.
europepmc   +1 more source

Transarterial embolization with bleomycin-lipiodol for symptomatic multifocal hepatic hemangiomas: Concurrent nontarget lesion devascularization via permitted reflux. [PDF]

Radiol Case Rep
Chow TKD, Hwang JJ, Malik A.
europepmc   +1 more source

Efficacy and safety of transarterial chemoembolization combined with donafenib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus: a dual-center, retrospective propensity score-matched analysis. [PDF]

Front Immunol
Zhang Q, Qing H, Lei Z, Xie X.
europepmc   +1 more source